Loading...

A comparison between the administration of oral prolonged-release oxycodone-naloxone and transdermal fentanyl in patients with moderate-to-severe cancer pain: a propensity score analysis

BACKGROUND: Opioids are the most important pharmacological treatment for moderate-to-severe cancer pain, but side effects limit their use. Transdermal fentanyl (TDF) and oral prolonged-release oxycodone-naloxone (OXN-PR) are effective in controlling chronic pain, with less constipation compared to o...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Pain Res
Main Authors: Roberto, A, Greco, MT, Legramandi, L, Galli, F, Galli, M, Corli, O
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5590764/
https://ncbi.nlm.nih.gov/pubmed/28919810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S141928
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!